Group One Trading’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.2M | Buy |
261,443
+49,626
| +23% | +$1.6M | 0.01% | 935 |
|
|
2026
Q1 | $6.89M | Buy |
211,817
+68,202
| +47% | +$2.19M | 0.01% | 1077 |
|
|
2025
Q4 | $5.05M | Buy |
143,615
+107,798
| +301% | +$3.82M | 0.01% | 1471 |
|
|
2025
Q3 | $941K | Sell |
35,817
-113,398
| -76% | -$3.38M | ﹤0.01% | 3098 |
|
|
2025
Q2 | $3.95M | Buy |
149,215
+26,543
| +22% | +$699K | 0.01% | 1506 |
|
|
2025
Q1 | $2.96M | Sell |
122,672
-144,081
| -54% | -$4.55M | 0.01% | 1482 |
|
|
2024
Q4 | $10.7M | Buy |
266,753
+2,645
| +1% | +$151K | 0.02% | 657 |
|
|
2024
Q3 | $16.7M | Buy |
264,108
+62,814
| +31% | +$3.69M | 0.05% | 345 |
|
|
2024
Q2 | $10.7M | Buy |
201,294
+127,049
| +171% | +$8.33M | 0.04% | 416 |
|
|
2024
Q1 | $6.09M | Buy |
74,245
+51,320
| +224% | +$2.28M | 0.02% | 705 |
|
|
2023
Q4 | $427K | Sell |
22,925
-504,536
| -96% | -$6.6M | ﹤0.01% | 3198 |
|
|
2023
Q3 | $5.84M | Buy |
527,461
+31,966
| +6% | +$457K | 0.02% | 849 |
|
|
2023
Q2 | $8.03M | Sell |
495,495
-20,457
| -4% | -$429K | 0.03% | 638 |
|
|
2023
Q1 | $8.59M | Sell |
515,952
-235,959
| -31% | -$2.44M | 0.03% | 557 |
|
|
2022
Q4 | $7.07M | Buy |
751,911
+604,295
| +409% | +$2.7M | 0.02% | 935 |
|
|
2022
Q3 | $402K | Buy |
147,616
+26,458
| +22% | +$86.7K | ﹤0.01% | 3451 |
|
|
2022
Q2 | $350K | Buy |
121,158
+1,214
| +1% | +$3K | ﹤0.01% | 3761 |
|
|
2022
Q1 | $360K | Buy |
119,944
+30,528
| +34% | +$110K | ﹤0.01% | 4187 |
|
|
2021
Q4 | $411K | Buy |
89,416
+16,651
| +23% | +$93.3K | ﹤0.01% | 4358 |
|
|
2021
Q3 | $457K | Buy |
72,765
+9,599
| +15% | +$59.3K | ﹤0.01% | 4299 |
|
|
2021
Q2 | $378K | Sell |
63,166
-6,107
| -9% | -$36.3K | ﹤0.01% | 4532 |
|
|
2021
Q1 | $438K | Sell |
69,273
-258,124
| -79% | -$1.82M | ﹤0.01% | 4206 |
|
|
2020
Q4 | $1.84M | Buy |
327,397
+188,463
| +136% | +$1.14M | ﹤0.01% | 2125 |
|
|
2020
Q3 | $809K | Buy |
138,934
+10,543
| +8% | +$72.6K | ﹤0.01% | 2399 |
|
|
2020
Q2 | $926K | Sell |
128,391
-1,323
| -1% | -$8.79K | ﹤0.01% | 2095 |
|
|
2020
Q1 | $607K | Buy |
129,714
+114,641
| +761% | +$705K | ﹤0.01% | 1916 |
|
|
2019
Q4 | $121K | Sell |
15,073
-106,361
| -88% | -$775K | ﹤0.01% | 3514 |
|
|
2019
Q3 | $835K | Buy |
121,434
+88,820
| +272% | +$660K | 0.01% | 1886 |
|
|
2019
Q2 | $271K | Sell |
32,614
-42,670
| -57% | -$365K | ﹤0.01% | 2630 |
|
|
2019
Q1 | $748K | Sell |
75,284
-119,988
| -61% | -$1M | 0.01% | 1623 |
|
|
2018
Q4 | $1.49M | Sell |
195,272
-236,241
| -55% | -$2.82M | 0.01% | 1214 |
|
|
2018
Q3 | $7.52M | Buy |
431,513
+256,658
| +147% | +$3.05M | 0.06% | 379 |
|
|
2018
Q2 | $1.66M | Buy |
174,855
+145,896
| +504% | +$970K | 0.01% | 1281 |
|
|
2018
Q1 | $127K | Buy |
+28,959
| New | +$160K | ﹤0.01% | 3107 |
|
Other funds holding VKTX
Group One Trading's VKTX Position: Q2 2026 in Review
Group One Trading increased its Viking Therapeutics (VKTX) stake by 23% in Q2 2026, buying an estimated $1.6M and bringing the position to 261,443 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #935.
Group One Trading first reported a position in VKTX in Q1 2018 and has held it in 34 quarters since. The position peaked at $16.7M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Group One Trading held 261,443 shares of Viking Therapeutics worth $10.2M as of Q2 2026.
- Group One Trading bought 49,626 Viking Therapeutics shares in Q2 2026, an estimated $1.6M.
- Viking Therapeutics made up 0.01% of Group One Trading's portfolio in Q2 2026, its #935 holding.
- Group One Trading first reported a position in Viking Therapeutics in Q1 2018 and has held it in 34 quarters since.
- Group One Trading's Viking Therapeutics position peaked at $16.7M in Q3 2024.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.